Institute of Biomedical Research Corp. (MRES)
OTCMKTS · Delayed Price · Currency is USD
0.0022
0.00 (0.00%)
Sep 24, 2026, 2:44 PM EST
MRES Market Cap
MRES has a market cap or net worth of $6.05 million as of September 25, 2026. Its market cap has decreased by -72.50% in one year.
Market Cap
6.05M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since March 31, 2016, MRES's market cap has increased from 693.95K to 6.05M, an increase of 771.61%. That is a compound annual growth rate of 22.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 6.05M | -21.43% |
| Dec 31, 2025 | 7.70M | -83.96% |
| Dec 31, 2024 | 47.98M | 138.03% |
| Dec 29, 2023 | 20.16M | 17.54% |
| Dec 30, 2022 | 17.15M | 149.69% |
| Dec 31, 2021 | 6.87M | 971.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hepion Pharmaceuticals | 7.48M |
| Curative Biotechnology | 7.15M |
| Reviva Pharmaceuticals Holdings | 6.82M |
| LianMedical | 6.44M |
| TRON Group | 6.15M |
| Adaptimmune Therapeutics | 6.10M |
| Pacific Software | 4.98M |
| Zenith Capital | 4.83M |